UK clinical trials show early signs of recovery

Data from the UK's Medicines and Healthcare Products Regulatory Agency presented at the JP Morgan Healthcare Conference 2026 indicates a 9% increase in clinical trial applications. This suggests a positive initial impact from recent regulatory reform efforts aimed at speeding up approvals and simplifying lower-risk trials.